High-Throughput Screening Market Players:
- Carna Biosciences, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Agilent Technologies, Inc.,
- Thermo Fisher Scientific
- Tecan Trading AG
- Promega Corporation
- Hamilton Company
- BPS Bioscience, Inc.
- PerkinElmer Inc.
- Merck KGaA
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of high-throughput screening is evaluated at USD 29.75 billion.
The global high-throughput screening market size was worth over USD 27.14 billion in 2025 and is poised to grow at a CAGR of around 10.7%, reaching USD 75 billion revenue by 2035.
North America high-throughput screening market will hold around 40.6% share by 2035, driven by growing pharmaceutical R&D and chronic disease burden.
Key players in the market include Carna Biosciences, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Tecan Trading AG, Promega Corporation, Hamilton Company, BPS Bioscience, Inc., PerkinElmer Inc., Merck KGaA.
